Company Filing History:
Years Active: 2024
Title: Roxana F Schlam: Innovator in Pharmaceutical Science
Introduction
Roxana F Schlam is a prominent inventor based in Hod Hasharon, Israel. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for thromboembolic disorders. Her work exemplifies the intersection of chemistry and medicine, showcasing the importance of research in improving patient outcomes.
Latest Patents
Roxana holds a patent for "Crystalline forms of a PAR4 inhibitor." This invention relates to co-crystals of a specific compound, where the co-former molecule is either succinic acid or citric acid. The patent outlines processes for preparing the co-crystal, pharmaceutical compositions derived from it, and methods for using these co-crystals in treating or preventing thromboembolic disorders. This patent highlights her commitment to advancing therapeutic options in the medical field.
Career Highlights
Roxana is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Her role there has allowed her to collaborate with other talented professionals in the industry, contributing to groundbreaking research and development efforts. Her dedication to innovation is evident in her work and the impact it has on healthcare.
Collaborations
Roxana has worked alongside notable colleagues, including Nicolas Cuniere and Victoria A Mbachu. These collaborations have fostered a dynamic environment for research and development, enhancing the potential for new discoveries in the pharmaceutical sector.
Conclusion
Roxana F Schlam is a distinguished inventor whose work in pharmaceutical science has the potential to transform treatment options for thromboembolic disorders. Her innovative spirit and dedication to research continue to inspire advancements in medicine.